Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.68 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.50 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthrarobin SCHEMBL29404728 | 1.00 | PTPN22 (0.68) | PTPN22TRPM4NQO2HDAC3HDAC4 | |
| Anthrarobin SCHEMBL29523367 | 1.00 | PTPN22 (0.68) | PTPN22TRPM4NQO2HDAC3HDAC4 | |
| SCHEMBL25428008 | 0.83 | ALDH1A1 (0.62) | PTPN22TRPM4HDAC3HDAC4HDAC1 | |
| SCHEMBL30196661 | 0.83 | CYP1A2 (0.60) | PTPN22TRPM4NQO2HDAC3HDAC4 | |
| SCHEMBL2002444 | 0.83 | CYP1A2 (0.60) | PTPN22TRPM4NQO2HDAC3HDAC4 | |
| SCHEMBL13763201 | 0.82 | PTPN22 (0.55) | PTPN22TRPM4NQO2ALOX5ALDH1A1 | |
| SCHEMBL30822054 | 0.82 | PTPN22 (0.55) | PTPN22TRPM4NQO2ALOX5ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28347175 | 0.81 | PTPN22 (1.00) | PTPN22ALDH1A1HSD17B10IDO1CYP1A2 | |
| SCHEMBL29613822 | 0.81 | PTPN22 (1.00) | PTPN22ALDH1A1HSD17B10IDO1CYP1A2 | |
| SCHEMBL28483 | 0.81 | PTPN22 (1.00) | PTPN22ALDH1A1HSD17B10IDO1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1001 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| CN-110337590-A | The identification and treatment of tumour characterized by neonatal Fc receptor is overexpressed | 奥胡斯大学 | 2019-10-15 | — | — | CN | claimed |
| CN-109900774-A | MALDI-TOF-MS is improved to the method for polystyrene micro-/ nano particle detections sensitivity by high-temperature process | 中国科学院生态环境研究中心 | 2019-06-18 | — | — | CN | claimed |
| CN-109789146-A | chemokine receptor modulators and uses thereof | FLX生物公司 | 2019-05-21 | — | — | CN | claimed |
| US-6153226-A | VIRICIDAL COMPOSITION COMPRISING A SYNERGISTIC MIXTURE OF A PHENOL COMPONENT AND PROPOLIS; THE PHENOL IS A MONO- OR POLYHYDROXYLATED COMPOUND COMPRISING A NONFUSED OR FUSED BENZENE RING | FILECO (FR) | 2000-11-28 | — | — | US | claimed |
| CN-1260355-A | Anti-reflection coating polymer and preparing method thereof | HYUNDAI ELECTRONICS IND (KR) | 2000-07-19 | — | — | CN | claimed |
| CN-1047472-C | Solid state electrochemical cell containing a proton-donating aromatic compound | ELECTRO CHEM RES (IL) | 1999-12-15 | — | — | CN | claimed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | claimed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | claimed |
| CN-1056813-A | The therapeutic combination that contains a kind of phenolic compounds and propolis is as against lipid capsid viruses, particularly anti-herpesvirus | FILECO SA (FR) | 1991-12-11 | — | — | CN | claimed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| US-4954345-A | CORTICOSTEROIDS AND-OR TRIHYDROXYANTHRACENES | ROHM PHARMA GMBH (DE) | 1990-09-04 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4269952-A | Preparation of glycidyl polyarylethers | RHONE-POULENC INDUSTRIES (FR) | 1981-05-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | PTPN22 4628/4885TRPM4 1231/4885NQO2 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.